Global Laboratory Landscape Data for Targeted Pharma Therapy Launches: Are You Ready? | Diaceutics

Global Laboratory Landscape Data for Targeted Pharma Therapy Launches: Are You Ready?

May 1st, 2016

Mark Reis
Ryan Keeling
Jordan Clark


Will you be launching a targeted therapy in the next 24 to 48 months? This Labceutics webinar provides key insights into laboratory strategy, data and key market landscape differences when planning for a targeted therapy launch.

Join an expert panel of targeted therapy and laboratory data experts to hear about the ‘forgotten’ but critical stakeholder in successful global targeted therapy launches – the molecular laboratory.

Listen to this webinar to learn:

  • How the laboratory landscape and testing environment impacts therapy launches globally
  • Laboratory Mapping and optimal lab footprints based on a therapy, a test and target prescribers
  • The types of biomarker testing being done on a regional basis
  • Key testing measurement criteria about laboratories you need to know
  • Challenges and opportunities in developing regional lab networks to support quality testing

Expert Insights

April 19th, 2018
The CMS National Coverage Decision on NGS
I. Introduction On March 16, 2018, the Centers for Medicare and Medicaid Services (CMS) finalized a National Coverage Determination (NCD) that cove...
January 19th, 2018
What does the EU IVD Regulation mean for companion diagnostics and LDTs?
Dave Smart, PhD, Director at Diaceutics, discusses the introduction of the EU IVD Regulation. While it is considered a necessary step, the Regulati...
View all expert insights

Competitive Benchmarking Reports

March 16th, 2018
PM Readiness Report 2018 Summary
March 14th, 2017
Pharma Readiness for Diagnostic Integration 2017
View all reports

Publications

May 23rd, 2019
Diaceutics reviews the ongoing debate on diagnostics reform legislation
Thought leaders at Diaceutics recently authored a peer-reviewed article that covers the ongoing national debate over diagnostics reform legislation in the United States. The article is now available online ahead of print in the Journal of Molecula...
September 11th, 2018
BRAF mutation testing in melanoma – Poster presented at European Congress of Pathology 2018
BRAF mutation testing in melanoma: a study including Austria, Germany and UK, highlighting concordance for current technologies, and potential requirement of more sensitive technologies in future applications.
View all publications
Facebook
Twitter
YouTube
LinkedIn